Review
doi: 10.1517/14656566.8.7.935.
The management of psychosis in movement disorder patients
Affiliations
- PMID: 17472539
- DOI: 10.1517/14656566.8.7.935
Item in Clipboard
Review
The management of psychosis in movement disorder patients
Expert Opin Pharmacother.
2007 May.
Abstract
Psychosis may be seen with several movement disorders. As pharmacological treatments can sometimes worsen movement disorders, psychosis in these situations can be complex for clinicians to manage. This review covers the management of psychosis in three different movement disorders: Parkinson's disease, dementia with Lewy bodies and Huntington's disease.
Similar articles
-
Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.Am J Psychiatry. 2007 Oct;164(10):1491-8. doi: 10.1176/appi.ajp.2007.07040715. Am J Psychiatry. 2007. PMID: 17898337 Free PMC article. Review.
-
Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.J Clin Psychiatry. 2004;65 Suppl 11:16-22. J Clin Psychiatry. 2004. PMID: 15264967 Review.
-
Clozapine and risperidone treatment of psychosis in Parkinson's disease.J Neuropsychiatry Clin Neurosci. 2000 Summer;12(3):364-9. doi: 10.1176/jnp.12.3.364. J Neuropsychiatry Clin Neurosci. 2000. PMID: 10956570 Clinical Trial.
-
Pharmacologic management of psychosis in the elderly: a critical review.J Geriatr Psychiatry Neurol. 2003 Dec;16(4):213-8. doi: 10.1177/0891988703258663. J Geriatr Psychiatry Neurol. 2003. PMID: 14653429 Review.
-
The emerging role of clozapine in the treatment of movement disorders.Mov Disord. 1997 Jul;12(4):483-96. doi: 10.1002/mds.870120403. Mov Disord. 1997. PMID: 9251065 Review.
Cited by
-
The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.Case Rep Psychiatry. 2015;2015:742471. doi: 10.1155/2015/742471. Epub 2015 Sep 16. Case Rep Psychiatry. 2015. PMID: 26451266 Free PMC article.
-
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.Cell Rep. 2014 Nov 6;9(3):930-43. doi: 10.1016/j.celrep.2014.10.008. Epub 2014 Oct 30. Cell Rep. 2014. PMID: 25437550 Free PMC article.
-
Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.Neuropsychopharmacology. 2010 Mar;35(4):881-92. doi: 10.1038/npp.2009.176. Epub 2009 Nov 11. Neuropsychopharmacology. 2010. PMID: 19907417 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
